Welcome!

News Feed Item

Florida Institute and Dawson James Securities Complete Integene International Holdings Financing

The Florida Institute for the Commercialization of Public Research (Florida Institute) announced today that it has finalized a funding agreement with Integene International Holdings (Integene), a vascular biotechnology company that has developed platform technology for ischemia and associated complications. The Institute supports new company creation based on publicly-funded research across the state, and bridges early funding gaps for companies spinning out of universities and research institutions. In order to qualify for Florida Institute funding, companies must raise matching private investment capital.

In December 2013, the Florida Institute and Dawson James Securities, Inc. (“Dawson James”, Member FINRA/SPIC) announced an alliance to augment early investment in emerging growth innovation companies. Companies undergo a thorough review and vetting process led by the Florida Institute, who provides up to $300,000 in funding to qualified companies. Through the partnership, Dawson James leverages its vast retail investor network to provide the required matching investment. In this case, Dawson James was able to raise more funding than what was required to match Florida Institute funds.

Integene was founded to capitalize on patented biotechnology created to optimize gene and stem cell treatments for cardiovascular disease. The company’s founder, Dr. Keith Webster and his team, in association with the University of Miami, have developed procedures for targeting and regulating human growth factor genes within host tissues, and bio-engineering stem cells to provide optimized therapies for ischemia related disease.

According to Dr. Webster, “The fundraising support provided by Dawson James enabled us to rapidly and efficiently raise the required matching funds to qualify for funds provided by the Florida Institute. These funds will be used to advance the clinical testing of treatments for major life-threatening diseases, initially a condition known as critical limb ischemia for which limb amputation may be the only option for many patients and eventually multiple other cardiovascular indications, diabetic retinopathy and solid tumors.”

“Dawson James Securities has been assisting emerging growth companies since 2004, and is interested in identifying and supporting quality new companies spinning out of Florida’s research institutions,” said Robert Keyser, Jr., Dawson James CEO. “As a full-service boutique investment bank, we are pleased to leverage our broad investor placement capabilities to support the growth of promising Florida companies.”

“We formed this alliance to coordinate company financing from angel investors, venture capitalists, private equity and public markets and to expand Florida’s innovation platform and investor base,” said Jamie Grooms, CEO of the Institute. “The Integene financing represents the first transaction resulting from this alliance, and we will continue to work with Dawson James to support the next generation of great Florida companies.”

About the Florida Institute

Formed by the Florida Legislature in 2007, the Florida Institute for the Commercialization of Public Research is a non-profit organization that works collaboratively with the technology licensing and commercialization offices of Florida’s state universities and private research institutions to leverage a $2B+ research base and form investable companies that create clean jobs in new industries that are driving the global economy. Over 100 new company projects have been identified across the state, and the Institute deploys company building and funding programs to promising Florida startups. Thirty-two companies have been funded since the program’s inception.

About Dawson James Securities

Dawson James Securities, Inc., a member of FINRA/SPIC, is a full service investment bank headquartered in Boca Raton, FL. Individuals with interest in investment in emerging growth companies can contact an appropriate Dawson James representative at 561-391-5555.

About Integene International Holdings

Integene International Holdings is a biotech company that has developed a comprehensive treatment for cardiovascular ischemic disease using combinations of proprietary gene and stem cell procedures. Integene technology is based on more than 20 years of NIH-supported pre-clinical development and is currently initiating Phase I/II clinical trials for the treatment of peripheral artery disease (PAD) using these procedures.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his opening keynote at 20th Cloud Expo, Michael Maximilien, Research Scientist, Architect, and Engineer at IBM, discussed the full potential of the cloud and social data requires artificial intelligence. By mixing Cloud Foundry and the rich set of Watson services, IBM's Bluemix is the best cloud operating system for enterprises today, providing rapid development and deployment of applications that can take advantage of the rich catalog of Watson services to help drive insights from the vast t...
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...
Recently, IoT seems emerging as a solution vehicle for data analytics on real-world scenarios from setting a room temperature setting to predicting a component failure of an aircraft. Compared with developing an application or deploying a cloud service, is an IoT solution unique? If so, how? How does a typical IoT solution architecture consist? And what are the essential components and how are they relevant to each other? How does the security play out? What are the best practices in formulating...
In his session at @ThingsExpo, Arvind Radhakrishnen discussed how IoT offers new business models in banking and financial services organizations with the capability to revolutionize products, payments, channels, business processes and asset management built on strong architectural foundation. The following topics were covered: How IoT stands to impact various business parameters including customer experience, cost and risk management within BFS organizations.
SYS-CON Events announced today that Elastifile will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Elastifile Cloud File System (ECFS) is software-defined data infrastructure designed for seamless and efficient management of dynamic workloads across heterogeneous environments. Elastifile provides the architecture needed to optimize your hybrid cloud environment, by facilitating efficient...
As DevOps methodologies expand their reach across the enterprise, organizations face the daunting challenge of adapting related cloud strategies to ensure optimal alignment, from managing complexity to ensuring proper governance. How can culture, automation, legacy apps and even budget be reexamined to enable this ongoing shift within the modern software factory?
While some vendors scramble to create and sell you a fancy solution for monitoring your spanking new Amazon Lambdas, hear how you can do it on the cheap using just built-in Java APIs yourself. By exploiting a little-known fact that Lambdas aren’t exactly single-threaded, you can effectively identify hot spots in your serverless code. In his session at @DevOpsSummit at 21st Cloud Expo, Dave Martin, Product owner at CA Technologies, will give a live demonstration and code walkthrough, showing how ...
@DevOpsSummit at Cloud Expo taking place Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center, Santa Clara, CA, is co-located with the 21st International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is ...
SYS-CON Events announced today that Golden Gate University will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Since 1901, non-profit Golden Gate University (GGU) has been helping adults achieve their professional goals by providing high quality, practice-based undergraduate and graduate educational programs in law, taxation, business and related professions. Many of its courses are taug...
Historically, some banking activities such as trading have been relying heavily on analytics and cutting edge algorithmic tools. The coming of age of powerful data analytics solutions combined with the development of intelligent algorithms have created new opportunities for financial institutions. In his session at 20th Cloud Expo, Sebastien Meunier, Head of Digital for North America at Chappuis Halder & Co., discussed how these tools can be leveraged to develop a lasting competitive advantage ...
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
An increasing number of companies are creating products that combine data with analytical capabilities. Running interactive queries on Big Data requires complex architectures to store and query data effectively, typically involving data streams, an choosing efficient file format/database and multiple independent systems that are tied together through custom-engineered pipelines. In his session at @BigDataExpo at @ThingsExpo, Tomer Levi, a senior software engineer at Intel’s Advanced Analytics ...
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
When shopping for a new data processing platform for IoT solutions, many development teams want to be able to test-drive options before making a choice. Yet when evaluating an IoT solution, it’s simply not feasible to do so at scale with physical devices. Building a sensor simulator is the next best choice; however, generating a realistic simulation at very high TPS with ease of configurability is a formidable challenge. When dealing with multiple application or transport protocols, you would be...